786 related articles for article (PubMed ID: 33013699)
1. Causal Effects of Genetically Determined Metabolites on Risk of Polycystic Ovary Syndrome: A Mendelian Randomization Study.
Sun S; Jiao M; Han C; Zhang Q; Shi W; Shi J; Li X
Front Endocrinol (Lausanne); 2020; 11():621. PubMed ID: 33013699
[No Abstract] [Full Text] [Related]
2. Causality of genetically determined metabolites on anxiety disorders: a two-sample Mendelian randomization study.
Xiao G; He Q; Liu L; Zhang T; Zhou M; Li X; Chen Y; Chen Y; Qin C
J Transl Med; 2022 Oct; 20(1):475. PubMed ID: 36266699
[TBL] [Abstract][Full Text] [Related]
3. Body Mass Index and Polycystic Ovary Syndrome: A 2-Sample Bidirectional Mendelian Randomization Study.
Zhao Y; Xu Y; Wang X; Xu L; Chen J; Gao C; Wu C; Pan D; Zhang Q; Zhou J; Chen R; Wang Z; Zhao H; You L; Cao Y; Li Z; Shi Y
J Clin Endocrinol Metab; 2020 Jun; 105(6):. PubMed ID: 32163573
[TBL] [Abstract][Full Text] [Related]
4. Investigating the causal impact of polycystic ovary syndrome on gestational diabetes mellitus: a two-sample Mendelian randomization study.
Guixue G; Yifu P; Xiaofeng T; Qian S; Yuan G; Wen Y; Conghui H; Zuobin Z
Front Endocrinol (Lausanne); 2024; 15():1337562. PubMed ID: 38375192
[TBL] [Abstract][Full Text] [Related]
5. Is there a shared genetic basis and causal relationship between polycystic ovary syndrome and psychiatric disorders: evidence from a comprehensive genetic analysis.
Jiang X; Deng Q; Stener-Victorin E
Hum Reprod; 2021 Jul; 36(8):2382-2391. PubMed ID: 34051085
[TBL] [Abstract][Full Text] [Related]
6. Bidirectional Mendelian randomization to explore the causal relationships between body mass index and polycystic ovary syndrome.
Brower MA; Hai Y; Jones MR; Guo X; Chen YI; Rotter JI; Krauss RM; Legro RS; Azziz R; Goodarzi MO
Hum Reprod; 2019 Jan; 34(1):127-136. PubMed ID: 30496407
[TBL] [Abstract][Full Text] [Related]
7. Polycystic ovary syndrome and 25-hydroxyvitamin D: A bidirectional two-sample Mendelian randomization study.
Zhang N; Liao Y; Zhao H; Chen T; Jia F; Yu Y; Zhu S; Wang C; Zhang W; Liu X
Front Endocrinol (Lausanne); 2023; 14():1110341. PubMed ID: 36967791
[TBL] [Abstract][Full Text] [Related]
8. Genetically Predicted Cigarette Smoking in Relation to Risk of Polycystic Ovary Syndrome.
Tao Y; Liu B; Chen Y; Hu Y; Zhu R; Ye D; Mao Y; Sun X
Clin Epidemiol; 2021; 13():527-532. PubMed ID: 34239329
[TBL] [Abstract][Full Text] [Related]
9. Genetic evidence for the causal association between type 1 diabetes and the risk of polycystic ovary syndrome.
Chen S; Guo Z; Yu Q
Hum Genomics; 2023 Nov; 17(1):100. PubMed ID: 37957681
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer risk in patients with polycystic ovary syndrome: a Mendelian randomization analysis.
Wen Y; Wu X; Peng H; Li C; Jiang Y; Su Z; Liang H; Liu J; He J; Liang W
Breast Cancer Res Treat; 2021 Feb; 185(3):799-806. PubMed ID: 33128677
[TBL] [Abstract][Full Text] [Related]
11. Gut microbiota and polycystic ovary syndrome, focus on genetic associations: a bidirectional Mendelian randomization study.
Wang J; Fiori PL; Capobianco G; Carru C; Chen Z
Front Endocrinol (Lausanne); 2024; 15():1275419. PubMed ID: 38318294
[TBL] [Abstract][Full Text] [Related]
12. Causal relationships between genetically determined metabolites and human intelligence: a Mendelian randomization study.
Yang J; Zhao B; Qian L; Gao F; Fan Y; He X; Ma Q; Yang L; Yan B; Wang W; Ma X
Mol Brain; 2021 Feb; 14(1):29. PubMed ID: 33563321
[TBL] [Abstract][Full Text] [Related]
13. Age at menarche and polycystic ovary syndrome: A Mendelian randomization study.
Ma Y; Cai J; Liu LW; Hou W; Wei Z; Wang Y; Xu Y
Int J Gynaecol Obstet; 2023 Sep; 162(3):1050-1056. PubMed ID: 37128830
[TBL] [Abstract][Full Text] [Related]
14. Causal relationships between modifiable risk factors and polycystic ovary syndrome: a comprehensive Mendelian randomization study.
Zhao Y; Pang J; Fang X; Yan Z; Yang H; Deng Q; Ma T; Lv M; Li Y; Tu Z; Zou L
Front Endocrinol (Lausanne); 2024; 15():1348368. PubMed ID: 38779450
[TBL] [Abstract][Full Text] [Related]
15. The causal association between polycystic ovary syndrome and susceptibility and severity of COVID-19: a bidirectional Mendelian randomization study using genetic data.
Si Y; Fei Y; Ma H; Xu Y; Ning L; Li X; Ren Q
Front Endocrinol (Lausanne); 2023; 14():1229900. PubMed ID: 37745707
[TBL] [Abstract][Full Text] [Related]
16. No association effect of genetic polymorphism was observed between polycystic ovary syndrome and cardiovascular diseases risk: a mendelian randomization study.
Zhang X; Huangfu Z; Wang S
Endocrine; 2023 Dec; 82(3):695-706. PubMed ID: 37668928
[TBL] [Abstract][Full Text] [Related]
17. Non-causal relationship of polycystic ovarian syndrome with homocysteine and B vitamins: evidence from a two-sample Mendelian randomization.
Su N; Li J; Xia Y; Huang C; Chen L
Front Endocrinol (Lausanne); 2024; 15():1393847. PubMed ID: 38841299
[TBL] [Abstract][Full Text] [Related]
18. Identification of genetic variants for blood insulin level in sex-stratified Korean population and evaluation of the causal relationship between blood insulin level and polycystic ovary syndrome.
Lim WY; Lee H; Cho YS
Genes Genomics; 2021 Oct; 43(10):1105-1117. PubMed ID: 34304350
[TBL] [Abstract][Full Text] [Related]
19. The Association Between Genetically Predicted Systemic Inflammatory Regulators and Polycystic Ovary Syndrome: A Mendelian Randomization Study.
Chen H; Zhang Y; Li S; Tao Y; Gao R; Xu W; Yang Y; Cheng K; Wang Y; Qin L
Front Endocrinol (Lausanne); 2021; 12():731569. PubMed ID: 34646235
[TBL] [Abstract][Full Text] [Related]
20. Maternal Polycystic Ovary Syndrome and Offspring Birth Weight: A Mendelian Randomization Study.
Gan Y; Lu D; Yan C; Zhang J; Zhao J
J Clin Endocrinol Metab; 2022 Mar; 107(4):1020-1029. PubMed ID: 34849988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]